Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Can someone explain

<< Previous

Bullboard Posts

Next >>

Comment by Trogarzonon Oct 15, 2023 8:39am

86 Views

Post# 35684199

RE:RE:RE:RE:Can someone explain

In the end what would IM achieve in terms of Sales improvement vs The pending Quick IV version. They only advantage is faster delivery but still need to take an appointment with a nurse from what ai understand. Lot of worries for something that is close to a non event in my mind.

<< Previous

Bullboard Posts

Next >>

Three micro-cap value stocks trading at peak pessimism